• EN
    • SV
  • About Us
    • Saniona
    • Vision, mission, values
    • Our strategy
    • Executive Team
    • Board of Directors
    • Our history
  • Our Science
    • Science overview
    • Ion channels
    • Publications & posters
    • Partnerships & spinouts
    • The discovery process
  • Our Programs
    • Pipeline overview
    • SAN2668
    • SAN2465
    • SAN2219
    • SAN903
    • Tesofensine
    • Tesomet
    • The development process
  • Patients & Caregivers
    • Indication overview
    • Epilepsy
    • Major depressive disorder
    • Rare diseases
    • Hypothalamic obesity
    • Prader-Willi syndrome
  • Investor Relations
    • Investors overview
    • The Share
    • Financial Calendar
    • Financial reports and filings
    • Analyst Coverage
    • Events and Presentations
    • FAQs
    • Corporate governance
  • Newsroom
    • Latest news
    • Press Releases
    • Interviews
    • Media Kit
  • Join Us
    • Overview
    • Working with us
    • Current Openings
Saniona
  • EN
  • SV
INVESTORS

Audit Committee

Saniona Icon blue
  • Overview
  • The Share
    • Share Information
    • Ownership Structure
  • Financial Calendar
  • Reports & Fillings
    • Annual & Quarterly Reports
    • Prospectus
    • Old prospectus
  • Analysts
  • Events and Presentations
  • FAQs
  • Corporate governance
    • Executive Team
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Shareholder Meetings
    • Nomination Committee
    • Auditors
    • Remuneration Incentive Programs

Audit Committee

The Board of Directors has established an Audit Committee. The members of the Audit Committee are Anna Ljung and Carl Johan Sundberg. Anna Ljung is Chairman of the Audit Committee.

Anna LjungJørgen DrejerCarl Johan Sundberg
  • Member
  • Chair
  • Financial Expert
  • Independent Director
  • About Us
    • Saniona
    • Vision, mission, values
    • Our strategy
    • Executive Team
    • Board of Directors
    • Our history
  • Our Science
    • Science overview
    • Ion channels
    • Publications & posters
    • Partnerships & spinouts
    • The discovery process
  • Our Programs
    • Pipeline overview
    • SAN2668
    • SAN2465
    • SAN2219
    • SAN903
    • Tesofensine
    • Tesomet
    • The development process
  • Patients & Caregivers
    • Indication overview
    • Epilepsy
    • Major depressive disorder
    • Rare diseases
    • Hypothalamic obesity
    • Prader-Willi syndrome
  • Investor Relations
    • Investors overview
    • The Share
    • Financial Calendar
    • Financial reports and filings
    • Analyst Coverage
    • Events and Presentations
    • FAQs
    • Corporate governance
  • Newsroom
    • Latest news
    • Press Releases
    • Interviews
    • Media Kit
  • Join Us
    • Overview
    • Working with us
    • Current Openings
Saniona
DENMARK

Murervangen 42
DK-2600 Glostrup
Denmark
+45 7070 5225
saniona@saniona.com

CONNECT 
  • Follow
  • Follow
  • Follow

© 2026 Saniona. All rights reserved.

Privacy Policy